Specialty Pharmacy

Cardiovascular disease (CVD) costs the United States $444 billion each year.

Oregon woman infected with HCV from a blood transfusion was at death’s door until she was cured by Harvoni.

Research may lead to new drugs that boost the immune response to HIV.

Novel drug delivers enzyme replacement therapies directly to the brain.

Breakthrough Therapy Designation nivolumab (Opdivo) granted for previously treated recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) after platinum based therapy.

Top news of the day from across the health care landscape.

Epigenetic changes seen in HIV-positive patients can cause biologic aging.

Affordable Care Act provides reimbursements for diabetes self-management education and support programs for pharmacists with recognized credentials.

Cabometyx targets multiple tyrosine kinases involved in the development of renal cell carcinoma.

The interests of payors, physicians, and patients must be addressed for biosimilars to offer cost savings.

Study highlights importance of a healthy lifestyle in patients with diabetes.

Researchers explore why ocular and facial muscles are spared in patients with Duchenne muscular dystrophy.

Rapid plasma genotyping technique allow for more rapid test results in non-small cell lung cancer.

Mevalonate pathway associated with cell-signaling protein that promotes breast cancer development.

Top news of the day from across the health care landscape.

In some cases, Raynaud's Disease can cause blood circulation to fingers and toes to permanently diminish, leading to deformities.

Study finds 12 total drug classes that can cause Raynaud’s disease.

Chiasma told it had not provided enough evidence of the drug’s efficacy to warrant an approval.

A pair of FDA final guidance documents may help drug manufacturers reduce the risk of deadly medication errors.

Blue-green algae discovered in Panama carries potent anti-cancer activity.

Current CDC testing guidelines fall short of solving the problem of undiagnosed patients with hepatitis C.

United States Preventive Services Task Force states screening for chronic obstructive pulmonary disease not be performed without symptoms of the disease.

Recent advances and updates in oncology and cancer drug development.

Gastrointestinal stromal tumors result in higher mortality than originally estimated.

TZD-based medicines effectively improve glucose uptake.

Medi-551 antibody targets the protein CD19 found on the surface of multiple myeloma stem cells.

Top news of the day from across the health care landscape.

Ocrelizumab shows potential treating both relapsing and primary progressive forms of multiple sclerosis.